prima's expanding and mergingr intent

Prima BioMed’s incoming CEO to refocus company on CVac


http://www.lifescientist.com.au/article/427092/prima_biomed_incoming_ceo_refocus_company_cvac/



Some of the points made in this extract below by incoming CEO Mathew Lehman strongly support the idea that Prima is looking at both the options of expanding internally and merging to become more economically efficient- -- economies of scale argument:

cheers
Birdseye


“There are opportunities for acquiring additional technology, products, or even companies to complement our existing assets in the personalized bio-therapeutics field. We are continuously looking at incremental innovation in cell therapy to reduce costs of production, enhance the potency of products, improve administration to the patients, and generally streamline processes.”


Lehman also outlined Prima’s future plans, emphasising the need to expand to handle additional development programmes and bring some services in-house.


“When it makes business sense, we may look at some vertical integration steps to bring some activities in-house that we currently contract out. We could also look at more strategic collaborations or risk-sharing endeavours with partners to build capacity while minimizing capital outlay,” he said.